Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

29.32 +0.39 (+1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 376,165
Open 29.00
Bid (Size) 29.30 (7)
Ask (Size) 29.32 (4)
Prev. Close 28.93
Today's Range 29.00 - 30.14
52wk Range 18.61 - 39.27
Shares Outstanding 56,769,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
Via Benzinga
Updates: HRMY, MELI, SWAV
​​​​​​​Another day, another slew of quarterly update reports for our followed stocks. 
Via Talk Markets

Performance

YTD
-4.77%
-4.77%
1 Month
-8.43%
-8.43%
3 Month
-5.54%
-5.54%
6 Month
+49.82%
+49.82%
1 Year
-7.45%
-7.45%

More News

Read More
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Analyst Ratings For Harmony Biosciences
Via Benzinga
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
Via InvestorPlace
NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
Via Chartmill
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts
Via Benzinga
The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
Via InvestorPlace
NASDAQ:HRMY: good value for what you're paying.
Via Chartmill
Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents.
Via Chartmill
Why Harmony Biosciences Stock Got Slammed Today
Via The Motley Fool
2023 Year In Review
Via Talk Markets
Topics Stocks
Exposures US Equities
NASDAQ:HRMY is showing good growth, while it is not too expensive.
Via Chartmill
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
Via InvestorPlace
NASDAQ:HRMY, an undervalued stock with good fundamentals.
Via Chartmill
Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On
Via InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
Via Chartmill
NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying.
Via Chartmill
While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable.
Via Chartmill
Quick Look At Reports From ServiceNow, Chipotle, And Harmony
Via Talk Markets
NASDAQ:HRMY is an undervalued gem with solid fundamentals.
Via Chartmill
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.